BeLOVE: Berlin Longterm Observation of Vascular Events

The aim of BeLOVE is to improve prediction and mechanistic understanding of the course of cardiovascular diseases, both in the acute and chronic phase, in order to provide the basis for individualized disease management.

3000 patients recruited into BeLOVE

In February 2022 the 3000th patient was successfully recruited into BeLOVE.

Learn more about numbers & facts of BeLOVE

Start of the main phase of BeLOVE

After thorough piloting and establishment of infrastructures and investigation modules, the main phase of BeLOVE could be initiated as planned on January 1st, 2021.

Comprehensive analyses of samples from the first 2000 patients started

After completion of enrollment of study participants for the establishment phase of BeLOVE on December 31st, 2020, initial analyses of the acute phase and 3-month follow-up of patients in this phase of the study were started in autumn at BIH's Core Facilities and other research groups.

Start of the Establishment Phase of BeLOVE

After thorough examination of the study feasiblity, the Establishment Phase of BeLOVE was started in March, 2018.

Start of the BeLOVE Pilot Phase

On July 17th, 2017 the Pilot Phase of BeLOVE was initiated.

BeLOVE: Berlin Longterm Observation of Vascular Events

For Participants and Interested Parties

For Scientists

Numbers & Facts

Participating Clinical Departments and Research Groups

Study Organization

Cooperations

3000 patients recruited into BeLOVE

Start of the main phase of BeLOVE

Comprehensive analyses of samples from the first 2000 patients started

Start of the Establishment Phase of BeLOVE

Start of the BeLOVE Pilot Phase

Contact: